These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2910964)

  • 61. Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study.
    Suchonwanit P; Iamsumang W; Rojhirunsakool S
    Am J Clin Dermatol; 2019 Feb; 20(1):147-153. PubMed ID: 30206824
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tretinoin enhances minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes.
    Sharma A; Goren A; Dhurat R; Agrawal S; Sinclair R; Trüeb RM; Vañó-Galván S; Chen G; Tan Y; Kovacevic M; Situm M; McCoy J
    Dermatol Ther; 2019 May; 32(3):e12915. PubMed ID: 30974011
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Safety and efficacy of 2% topical minoxidil in the management of male pattern baldness in Chinese.
    Kuan YZ; Chen SY; Chen MJ; Wang CN; Chan HL
    Changgeng Yi Xue Za Zhi; 1990 Jun; 13(2):96-103. PubMed ID: 2224611
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia.
    Whiting DA
    J Am Acad Dermatol; 1993 May; 28(5 Pt 1):755-63. PubMed ID: 8496421
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Topical minoxidil therapy for hair regrowth.
    Rumsfield JA; West DP; Fiedler-Weiss VC
    Clin Pharm; 1987 May; 6(5):386-92. PubMed ID: 3311578
    [TBL] [Abstract][Full Text] [Related]  

  • 66. An immunologic mechanism for the therapeutic efficacy of minoxidil in alopecia areata.
    Namazi MR; Handjani F
    J Drugs Dermatol; 2004; 3(2):129-30. PubMed ID: 15098965
    [No Abstract]   [Full Text] [Related]  

  • 67. Case series of oral minoxidil for androgenetic and traction alopecia: Tolerability & the five C's of oral therapy.
    Beach RA
    Dermatol Ther; 2018 Nov; 31(6):e12707. PubMed ID: 30246901
    [No Abstract]   [Full Text] [Related]  

  • 68. [Efficacy and tolerability of 5% minoxidil solution (Carexidil®) in male and female androgenetic alopecia: a 6-month open multicentric study].
    Piraccini B; Starace M; Alessandrini A; Guarrera M; Fiorucci MC; Lorenzi S
    G Ital Dermatol Venereol; 2011 Dec; 146(6 Suppl 1):1-8. PubMed ID: 22189834
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treatment of pediatric alopecia areata with anthralin: A retrospective study of 37 patients.
    Wu SZ; Wang S; Ratnaparkhi R; Bergfeld WF
    Pediatr Dermatol; 2018 Nov; 35(6):817-820. PubMed ID: 30338548
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Topical minoxidil in early male pattern baldness.
    Olsen EA; Weiner MS; Delong ER; Pinnell SR
    J Am Acad Dermatol; 1985 Aug; 13(2 Pt 1):185-92. PubMed ID: 3900155
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Androgenetic alopecia: treatment results with topical minoxidil.
    Roberts JL
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):705-10. PubMed ID: 3549805
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Minoxidil dose response study in female pattern hair loss patients determined to be non-responders to 5% topical minoxidil.
    McCoy J; Goren A; Kovacevic M; Shapiro J
    J Biol Regul Homeost Agents; 2016; 30(4):1153-1155. PubMed ID: 28078868
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Preparation and in vivo evaluation of lecithin-based microparticles for topical delivery of minoxidil.
    Lee HJ; Oh DW; Na MJ; Kim DW; Yuk DY; Choi HC; Lee YB; Han K; Park CW
    Arch Pharm Res; 2017 Aug; 40(8):943-951. PubMed ID: 28770536
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial.
    Panahi Y; Taghizadeh M; Marzony ET; Sahebkar A
    Skinmed; 2015; 13(1):15-21. PubMed ID: 25842469
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prevention of temporal alopecia following rhytidectomy: the prophylactic use of minoxidil. A study of 60 patients.
    Eremia S; Umar SH; Li CY
    Dermatol Surg; 2002 Jan; 28(1):66-74. PubMed ID: 11991275
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hair follicle biology and topical minoxidil: possible mechanisms of action.
    Headington JT
    Dermatologica; 1987; 175 Suppl 2():19-22. PubMed ID: 3319729
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The penetration enhancer SEPA augments stimulation of scalp hair growth by topical minoxidil in the balding stumptail macaque.
    Diani AR; Shull KL; Zaya MJ; Brunden MN
    Skin Pharmacol; 1995; 8(5):221-8. PubMed ID: 8527153
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Topical minoxidil (3%) in extensive alopecia areata, including long-term efficacy.
    Price VH
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):737-44. PubMed ID: 3549810
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Action of topical minoxidil in the bald stump-tailed macaque.
    Uno H; Cappas A; Brigham P
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):657-68. PubMed ID: 3558911
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Long-term follow-up of men with male pattern baldness treated with topical minoxidil.
    Olsen EA; DeLong ER; Weiner MS
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):688-95. PubMed ID: 3549803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.